Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 10:55AM ET
2.58
Dollar change
+0.12
Percentage change
4.67
%
IndexRUT P/E- EPS (ttm)-3.49 Insider Own8.20% Shs Outstand50.32M Perf Week19.21%
Market Cap130.06M Forward P/E- EPS next Y-1.80 Insider Trans-2.27% Shs Float46.36M Perf Month25.30%
Income-172.80M PEG- EPS next Q-0.55 Inst Own109.96% Short Float18.03% Perf Quarter-22.44%
Sales130.38M P/S1.00 EPS this Y22.82% Inst Trans-4.70% Short Ratio8.73 Perf Half Y-26.22%
Book/sh2.44 P/B1.05 EPS next Y13.82% ROA-48.41% Short Interest8.36M Perf Year-85.44%
Cash/sh4.03 P/C0.64 EPS next 5Y- ROE-93.69% 52W Range1.92 - 24.13 Perf YTD-52.40%
Dividend Est.- P/FCF- EPS past 5Y-15.08% ROI-67.11% 52W High-89.33% Beta1.88
Dividend TTM- Quick Ratio4.37 Sales past 5Y202.67% Gross Margin22.24% 52W Low34.11% ATR (14)0.23
Dividend Ex-Date- Current Ratio5.26 EPS Y/Y TTM-2.89% Oper. Margin-130.22% RSI (14)58.00 Volatility8.13% 9.57%
Employees480 Debt/Eq1.11 Sales Y/Y TTM13.00% Profit Margin-132.54% Recom2.25 Target Price5.79
Option/ShortYes / Yes LT Debt/Eq1.10 EPS Q/Q10.34% Payout- Rel Volume0.56 Prev Close2.46
Sales Surprise0.00% EPS Surprise7.81% Sales Q/Q-4.69% EarningsMay 08 AMC Avg Volume957.42K Price2.58
SMA2016.89% SMA50-1.73% SMA200-65.56% Trades Volume136,911 Change4.67%
Date Action Analyst Rating Change Price Target Change
Apr-08-24Initiated BTIG Research Buy $6
Apr-05-24Upgrade CL King Neutral → Buy $6
Jan-12-24Downgrade RBC Capital Mkts Outperform → Sector Perform $14 → $6
Oct-13-23Downgrade BofA Securities Buy → Underperform $32 → $3
Aug-17-23Initiated CL King Neutral
Nov-11-22Initiated RBC Capital Mkts Outperform $23
Jul-14-22Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $20
Mar-02-22Resumed BofA Securities Buy $50
Feb-17-22Upgrade Morgan Stanley Equal-Weight → Overweight $50
Aug-18-21Initiated Cowen Outperform $70
Apr-19-24 08:30AM
Apr-18-24 01:36PM
Apr-17-24 08:30AM
Apr-15-24 08:30AM
Mar-13-24 04:02PM
03:34PM Loading…
Mar-05-24 03:34PM
Feb-26-24 09:00AM
Feb-22-24 10:51AM
07:10AM
Feb-21-24 04:49PM
04:05PM
Feb-20-24 04:25PM
Feb-05-24 10:00AM
08:30AM
Jan-08-24 08:30AM
08:30AM Loading…
Jan-03-24 08:30AM
Nov-29-23 04:05PM
Nov-25-23 11:43AM
Nov-23-23 06:30AM
Nov-16-23 02:46PM
Nov-09-23 04:05PM
Nov-07-23 04:31PM
04:05PM
Nov-02-23 10:00AM
09:35AM
Nov-01-23 09:00AM
Oct-31-23 02:00PM
10:01AM
Oct-30-23 04:05PM
Oct-27-23 11:42AM
12:31PM Loading…
Oct-19-23 12:31PM
Oct-17-23 05:36PM
09:35AM
Oct-16-23 08:14AM
Oct-13-23 07:21PM
09:50AM
Oct-12-23 04:05PM
Aug-29-23 04:05PM
Aug-14-23 09:24PM
Aug-02-23 05:55PM
04:05PM
Jul-13-23 08:30AM
Jul-10-23 01:09PM
10:48AM
Jun-15-23 06:56AM
Jun-06-23 04:05PM
May-30-23 07:30AM
May-05-23 06:14AM
May-04-23 09:13AM
May-03-23 06:35PM
04:05PM
Apr-30-23 05:50AM
Apr-25-23 08:30AM
Apr-23-23 07:03AM
Apr-12-23 09:05AM
08:30AM
Apr-03-23 07:01AM
Mar-25-23 08:26AM
Feb-22-23 04:05PM
Feb-17-23 04:16PM
Feb-15-23 05:54AM
Feb-14-23 12:10PM
Feb-13-23 05:45PM
04:05PM
Feb-07-23 10:00AM
Feb-06-23 10:00AM
Jan-25-23 08:30AM
Jan-09-23 08:30AM
Jan-03-23 06:10PM
Dec-23-22 05:20AM
Dec-22-22 11:21AM
Dec-20-22 04:05PM
Nov-28-22 08:00AM
Nov-26-22 05:00AM
Nov-16-22 09:09AM
Nov-11-22 01:15PM
Nov-09-22 07:24PM
04:05PM
Nov-08-22 06:25PM
04:05PM
Nov-04-22 08:30AM
Oct-27-22 09:00AM
Oct-26-22 04:05PM
Oct-24-22 06:36AM
Sep-21-22 03:24AM
Aug-30-22 04:05PM
Aug-15-22 09:00AM
Aug-09-22 09:44AM
Aug-04-22 06:27AM
Aug-02-22 08:45AM
Aug-01-22 11:15AM
11:14AM
10:02AM
Jul-28-22 09:44AM
Jul-21-22 09:30AM
Jul-13-22 09:55AM
Jun-24-22 05:10AM
Jun-14-22 03:12PM
07:07AM
Jun-13-22 04:01PM
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nash MarcSVP Operations and R&DMar 15 '24Sale2.132,3915,093242,510Mar 15 06:40 PM
Ahmed NabeelChief Financial OfficerMar 01 '24Sale3.151,5844,990322,877Mar 04 04:34 PM
Trigg LeslieChair and CEOFeb 15 '24Sale3.575,32018,992833,091Feb 16 05:29 PM
Ahmed NabeelChief Financial OfficerFeb 15 '24Sale3.574,40315,719312,594Feb 16 05:24 PM
Brottem John L.General CounselFeb 15 '24Sale3.573,34111,927245,046Feb 16 05:26 PM
Williamson Steven S.Chief Commercial OfficerFeb 15 '24Sale3.572,5008,925320,347Feb 16 05:31 PM
Racine Jean-OlivierChief Technology OfficerFeb 15 '24Sale3.571,8666,662271,830Feb 16 05:28 PM
Nash MarcSVP Operations and R&DFeb 15 '24Sale3.576172,203243,100Feb 16 05:27 PM
Nash MarcSVP Operations and R&DJan 16 '24Sale429.00678290,862243,717Jan 17 08:01 PM
Trigg LeslieChair and CEOJan 16 '24Sale4.298,12634,861838,411Jan 17 08:03 PM
Ahmed NabeelChief Financial OfficerJan 16 '24Sale4.291,7267,405316,997Jan 17 07:59 PM
Brottem John L.General CounselJan 16 '24Sale4.291,4806,349248,387Jan 17 08:00 PM
Williamson Steven S.Chief Commercial OfficerJan 16 '24Sale4.299964,273322,847Jan 17 08:04 PM
Porter Stacey L.Chief People OfficerJan 16 '24Sale4.297683,29561,448Jan 17 08:02 PM
Racine Jean-OlivierChief Technology OfficerJan 16 '24Sale4.297233,102273,696Jan 17 08:03 PM
Trigg LeslieChair and CEOJan 08 '24Sale5.4914,18877,892389,099Jan 08 08:34 PM
Ahmed NabeelChief Financial OfficerJan 08 '24Sale5.4910,70958,79276,819Jan 08 08:29 PM
Brottem John L.General CounselJan 08 '24Sale5.497,34440,31948,807Jan 08 08:30 PM
Williamson Steven S.Chief Commercial OfficerJan 08 '24Sale5.497,05538,732105,939Jan 08 08:35 PM
Porter Stacey L.Chief People OfficerJan 08 '24Sale5.494,76626,16558,630Jan 08 08:31 PM
Racine Jean-OlivierChief Technology OfficerJan 08 '24Sale5.493,90521,43873,781Jan 08 08:33 PM
Williamson Steven S.Chief Commercial OfficerNov 16 '23Sale4.763,58417,060112,994Nov 17 04:22 PM
Trigg LeslieChair and CEONov 16 '23Sale4.763,17515,113403,287Nov 17 04:19 PM
Ahmed NabeelChief Financial OfficerNov 16 '23Sale4.761,6437,82187,528Nov 17 04:08 PM
Brottem John L.General CounselNov 16 '23Sale4.761,4316,81256,151Nov 17 04:15 PM
Racine Jean-OlivierChief Technology OfficerNov 16 '23Sale4.767903,76077,686Nov 17 04:18 PM
Porter Stacey L.Chief People OfficerNov 16 '23Sale4.766713,19463,396Nov 17 04:17 PM
Nash MarcSVP Operations and R&DNov 16 '23Sale4.765622,67544,757Nov 17 04:15 PM
Ahmed NabeelChief Financial OfficerSep 01 '23Sale13.615457,41789,171Sep 05 04:04 PM
Trigg LeslieChair and CEOAug 16 '23Sale15.103,02845,723406,461Aug 17 04:41 PM
Ahmed NabeelChief Financial OfficerAug 16 '23Sale15.101,56523,63289,171Aug 17 04:26 PM
Brottem John L.General CounselAug 16 '23Sale15.101,36420,59657,581Aug 17 04:28 PM
Racine Jean-OlivierChief Technology OfficerAug 16 '23Sale15.1075211,35578,475Aug 17 04:39 PM
Porter Stacey L.Chief People OfficerAug 16 '23Sale15.106389,63464,066Aug 17 04:37 PM
Williamson Steven S.Chief Commercial OfficerAug 16 '23Sale15.106359,588116,577Aug 17 04:43 PM
Nash MarcSVP Operations and R&DAug 16 '23Sale15.105358,07844,998Aug 17 04:34 PM
Trigg LeslieChair and CEOAug 01 '23Option Exercise4.1120,00082,200429,489Aug 03 04:11 PM
Trigg LeslieChair and CEOAug 01 '23Sale20.2220,000404,462409,489Aug 03 04:11 PM
Ahmed NabeelChief Financial OfficerAug 01 '23Sale20.0799019,86990,736Aug 03 04:10 PM
Brottem John L.General CounselJul 19 '23Option Exercise9.481,41513,41460,360Jul 20 04:01 PM
Brottem John L.General CounselJul 19 '23Sale20.001,41528,30058,945Jul 20 04:01 PM
Trigg LeslieChair and CEOJul 03 '23Option Exercise4.1120,00082,200429,489Jul 05 05:39 PM
Trigg LeslieChair and CEOJul 03 '23Sale20.9020,000417,944409,489Jul 05 05:39 PM
Ahmed NabeelChief Financial OfficerJul 03 '23Sale21.7099021,48391,726Jul 05 05:38 PM
Brottem John L.General CounselJun 20 '23Option Exercise9.481,41413,40560,359Jun 21 04:01 PM
Brottem John L.General CounselJun 20 '23Sale21.971,41431,06658,945Jun 21 04:01 PM
Trigg LeslieChair and CEOJun 01 '23Option Exercise4.1120,00082,200429,489Jun 01 06:08 PM
Trigg LeslieChair and CEOJun 01 '23Sale21.1020,000421,920409,489Jun 01 06:08 PM
Ahmed NabeelChief Financial OfficerJun 01 '23Sale20.8399020,62292,716Jun 01 05:31 PM
Brottem John L.General CounselMay 17 '23Option Exercise9.481,41513,41461,677May 17 06:26 PM
Brottem John L.General CounselMay 17 '23Sale20.082,73254,85958,945May 17 06:26 PM
Trigg LeslieChair and CEOMay 16 '23Sale19.912,96258,973409,489May 16 08:30 PM
Ahmed NabeelChief Financial OfficerMay 16 '23Sale19.911,53230,50293,706May 16 08:32 PM
Brottem John L.General CounselMay 16 '23Sale19.911,33526,58060,262May 17 06:26 PM
Racine Jean-OlivierChief Technology OfficerMay 16 '23Sale19.9173514,63479,227May 16 08:35 PM
Williamson Steven S.Chief Commercial OfficerMay 16 '23Sale19.9168113,559117,212May 16 08:28 PM
Porter Stacey L.Chief People OfficerMay 16 '23Sale19.9162612,46464,704May 16 08:34 PM
Williamson Steven S.Chief Commercial OfficerMay 08 '23Sale19.8310,000198,300117,893May 08 05:59 PM
Trigg LeslieChair and CEOMay 03 '23Option Exercise4.0540,000161,983432,451May 05 06:11 PM
Brottem John L.General CounselMay 03 '23Option Exercise9.481,41413,40563,011May 05 06:13 PM
Trigg LeslieChair and CEOMay 03 '23Sale20.0040,000800,180412,451May 05 06:11 PM
Brottem John L.General CounselMay 03 '23Sale20.001,41428,28061,597May 05 06:13 PM
Ahmed NabeelChief Financial OfficerMay 03 '23Sale20.0099019,80095,238May 05 06:16 PM